Global Aquaculture Vaccines Market
Report Highlights
Aquaculture Vaccines Market Size And Forecast
According to Verified Market Research, the Global Aquaculture Vaccines Market was valued at USD 190 Million in 2018 and is projected to reach USD 300.25 Million by 2026, growing at a CAGR of 5.8% from 2019 to 2026.
Global Aquaculture Vaccines Market Outlook
Increasing adoption of the vaccines by the aquaculture farmers for increasing their income is one of the major factors expected to fuel the growth of global aquaculture vaccines market. Moreover, various government regulations for use of antibiotic in aquaculture and introduction of new products are also further projected to propel the market growth. For instance, in March 2018, Hipra launched Icthiovac VR/PD injectable vaccine. Besides, different financing and research programs for improvement of inventive vaccines is further boosting the market growth. On the other hand, stringent regulatory policies for approval of aquaculture vaccines is the major factor that might impede the growth of the market.
Global Aquaculture Vaccines Market Competitive Landscape
The Global Aquaculture Vaccines Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Zoetis Inc., HIPRA, Merck & Co., Inc., Tecnovax, Veterquimica S.A., Virbac, Elanco, Nisseiken Co., Ltd, Phibro Animal Health Corp, and Pfizer.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.